38596096|t|Mitochondrial dysfunction precedes hippocampal IL-1beta transcription and cognitive impairments after low-dose lipopolysaccharide injection in aged mice.
38596096|a|Acute cognitive impairments termed delirium often occur after inflammatory insults in elderly patients. While previous preclinical studies suggest mitochondria as a target for reducing neuroinflammation and cognitive impairments after LPS injection, fewer studies have evaluated the effects of a low-grade systemic inflammation in the aged brain. Thus, to identify the significance of mitochondrial dysfunction after a clinically relevant systemic inflammatory stimulus, we injected old-aged mice (18-20 months) with low-dose lipopolysaccharide (LPS, 0.04 mg/kg). LPS injection reduced mitochondrial respiration in the hippocampus 24 h after injection (respiratory control ratio [RCR], state3u/state4o; control = 2.82 +- 0.19, LPS = 2.57 +- 0.08). However, gene expression of the pro-inflammatory cytokine IL-1beta was increased (RT-PCR, control = 1.00 +- 0.30; LPS = 2.01 +- 0.67) at a more delayed time point, 48 h after LPS injection. Such changes were associated with cognitive impairments in the Barnes maze and fear chamber tests. Notably, young mice were unaffected by low-dose LPS, suggesting that mitochondrial dysfunction precedes neuroinflammation and cognitive decline in elderly patients following a low-grade systemic insult. Our findings highlight mitochondria as a potential therapeutic target for reducing delirium in elderly patients.
38596096	0	25	Mitochondrial dysfunction	Disease	MESH:D028361
38596096	47	55	IL-1beta	Gene	3553
38596096	74	95	cognitive impairments	Disease	MESH:D003072
38596096	111	129	lipopolysaccharide	Chemical	MESH:D008070
38596096	148	152	mice	Species	10090
38596096	160	181	cognitive impairments	Disease	MESH:D003072
38596096	189	197	delirium	Disease	MESH:D003693
38596096	216	228	inflammatory	Disease	MESH:D007249
38596096	248	256	patients	Species	9606
38596096	339	356	neuroinflammation	Disease	MESH:D000090862
38596096	361	382	cognitive impairments	Disease	MESH:D003072
38596096	389	392	LPS	Chemical	MESH:D008070
38596096	469	481	inflammation	Disease	MESH:D007249
38596096	539	564	mitochondrial dysfunction	Disease	MESH:D028361
38596096	602	614	inflammatory	Disease	MESH:D007249
38596096	646	650	mice	Species	10090
38596096	680	698	lipopolysaccharide	Chemical	MESH:D008070
38596096	700	703	LPS	Chemical	MESH:D008070
38596096	718	721	LPS	Chemical	MESH:D008070
38596096	881	884	LPS	Chemical	MESH:D008070
38596096	938	950	inflammatory	Disease	MESH:D007249
38596096	960	968	IL-1beta	Gene	3553
38596096	1016	1019	LPS	Chemical	MESH:D008070
38596096	1077	1080	LPS	Chemical	MESH:D008070
38596096	1126	1147	cognitive impairments	Disease	MESH:D003072
38596096	1206	1210	mice	Species	10090
38596096	1239	1242	LPS	Chemical	MESH:D008070
38596096	1260	1285	mitochondrial dysfunction	Disease	MESH:D028361
38596096	1295	1312	neuroinflammation	Disease	MESH:D000090862
38596096	1317	1334	cognitive decline	Disease	MESH:D003072
38596096	1346	1354	patients	Species	9606
38596096	1477	1485	delirium	Disease	MESH:D003693
38596096	1497	1505	patients	Species	9606
38596096	Positive_Correlation	MESH:D008070	3553
38596096	Association	MESH:D028361	3553
38596096	Positive_Correlation	MESH:D008070	MESH:D028361
38596096	Positive_Correlation	MESH:D008070	MESH:D007249
38596096	Positive_Correlation	MESH:D008070	MESH:D003072

